[SGMO] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -23.12%
YoY- -11.46%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 6,835 157,957 27,230 26,460 29,378 28,231 27,986 -61.02%
PBT -120,770 21,327 -51,714 -53,125 -43,091 -43,919 -37,563 118.30%
Tax -6,264 194 259 30 82 58 -67 1977.11%
NP -114,506 21,133 -51,973 -53,155 -43,173 -43,977 -37,496 110.91%
Tax Rate - -0.91% - - - - - -
Total Cost 121,341 136,824 79,203 79,615 72,551 72,208 65,482 51.03%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -1,675.29 13.38 -190.87 -200.89 -146.96 -155.78 -133.98 441.22%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.66 0.13 -0.32 -0.34 -0.29 -0.30 -0.26 86.40%
EPS Diluted -0.66 0.12 -0.32 -0.34 -0.29 -0.30 -0.26 86.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.